Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AutoCyte North Carolina LLC
Original Assignee
Mark R. Rutenberg
Akiva Rutenberg
Lanbrecht Piet Kok
Mathilde Elisabeth Boon
Laurie J. Mango
Neuromedical Systems, Inc.
Autocyte North Carolina, L.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mark R. Rutenberg, Akiva Rutenberg, Lanbrecht Piet Kok, Mathilde Elisabeth Boon, Laurie J. Mango, Neuromedical Systems, Inc., Autocyte North Carolina, L.L.C.filedCriticalMark R. Rutenberg
Priority claimed from PCT/US1995/000853external-prioritypatent/WO1995022749A2/en
Publication of CA2182793A1publicationCriticalpatent/CA2182793A1/en
Application grantedgrantedCritical
Publication of CA2182793CpublicationCriticalpatent/CA2182793C/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A semi-automated method of classifying a specimen for the presence of premalignant or malignant cells, including the steps of treating a specimen with immunochemical marker to provide a visual indication of cell proliferation, ranking individual objects in the specimen in an order according to the likelihood that each object has attributes consistent with a premalignant or malignant cell or cell cluster, selecting for display a set of said objects according to said ranking, and displaying images of said selected objects to facilitate review by an operator.
CA002182793A1994-02-141995-01-23Automated cytological specimen classification system and method
Expired - Fee RelatedCA2182793C
(en)